| 000 | 01298 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516055634.0 | ||
| 264 | 0 | _c20120112 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1538-067X | ||
| 024 | 7 |
_a10.1188/11.CJON.501-508 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoucher, Jean | |
| 245 | 0 | 0 |
_aPreemptive management of dermatologic toxicities associated with epidermal growth factor receptor inhibitors. _h[electronic resource] |
| 260 |
_bClinical journal of oncology nursing _cOct 2011 |
||
| 300 |
_a501-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aNursing Assessment |
| 650 | 0 | 4 | _aNursing Methodology Research |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aOlson, Linnea | |
| 700 | 1 | _aPiperdi, Bilal | |
| 773 | 0 |
_tClinical journal of oncology nursing _gvol. 15 _gno. 5 _gp. 501-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1188/11.CJON.501-508 _zAvailable from publisher's website |
| 999 |
_c21188929 _d21188929 |
||